What oral third‑generation cephalosporins are appropriate for uncomplicated community‑acquired infections, and what are the recommended dosing regimens for adults and children?

Oral Third-Generation Cephalosporins for Uncomplicated Community-Acquired Infections

For uncomplicated community-acquired infections, the appropriate oral third-generation cephalosporins are cefpodoxime, cefdinir, and cefixime, with cefuroxime (second-generation) also acceptable; avoid cefixime and ceftibuten for pneumococcal infections due to poor activity against S. pneumoniae.

Available Oral Third-Generation Cephalosporins

The following oral third-generation cephalosporins are recommended for community-acquired infections 1:

• Cefpodoxime
• Cefdinir
• Cefixime
• Ceftibuten
• Cefuroxime (second-generation, but grouped with third-generation for respiratory infections)
• Cefprozil (second-generation alternative)

Pediatric Dosing Regimens

For Pneumococcal Infections (S. pneumoniae with penicillin MIC ≤2.0 μg/mL)

Alternatives to amoxicillin 1:

• Cefpodoxime, cefuroxime, or cefprozil (specific doses not provided in guidelines, but listed as acceptable alternatives)
• These are second-line to high-dose amoxicillin (90 mg/kg/day)

For Haemophilus influenzae (β-lactamase producing)

Oral therapy 1:

• Cefdinir, cefixime, cefpodoxime, or ceftibuten (listed as alternatives)
• First-line remains amoxicillin-clavulanate (45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses)

Critical Limitation

Cefixime and ceftibuten have poor activity against S. pneumoniae, especially penicillin-resistant strains, and should NOT be used for acute bacterial sinusitis or pneumonia 2. This is a crucial pitfall—these agents are only appropriate when H. influenzae or other gram-negative pathogens are the primary concern, not for mixed respiratory infections where pneumococcus is likely.

Adult Dosing Regimens

While the pediatric guidelines provide the most detailed information, general adult dosing from clinical practice:

Cefdinir 3, 4, 5

• 300 mg twice daily OR 600 mg once daily for 5-10 days
• Effective for skin/soft tissue infections, respiratory tract infections
• Good activity against β-lactamase-producing H. influenzae and M. catarrhalis

Cefpodoxime 6, 7

• 200-400 mg twice daily for 5-10 days
• Maintains activity against S. pneumoniae
• Effective for respiratory and urinary tract infections

Cefixime 6, 8

• 400 mg once daily for 5-10 days
• Avoid for pneumococcal infections
• Appropriate for uncomplicated UTI, otitis media when H. influenzae suspected
• Higher rate of diarrhea compared to other agents

Cefuroxime axetil 2

• 250-500 mg twice daily
• Enhanced activity against β-lactamase-producing organisms
• Unpalatable suspension limits pediatric use

Clinical Indications by Infection Type

Upper Respiratory Tract Infections

• Acute otitis media: Cefdinir, cefpodoxime, cefixime (when H. influenzae likely) 9, 8
• Acute bacterial sinusitis: Cefpodoxime, cefdinir, cefuroxime (NOT cefixime or ceftibuten) 2
• Pharyngitis/tonsillitis: Generally prefer penicillin; cephalosporins are alternatives

Lower Respiratory Tract Infections

• Community-acquired pneumonia: Cefpodoxime, cefdinir (NOT cefixime or ceftibuten) 4, 9, 10
• Acute exacerbation of chronic bronchitis: Cefdinir, cefpodoxime 4

Skin and Soft Tissue Infections

• Uncomplicated skin infections: Cefdinir (300 mg BID for 10 days) 3, 4, 5
• Good coverage for S. aureus (methicillin-susceptible) and S. pyogenes

Urinary Tract Infections

• Uncomplicated UTI: Cefpodoxime, cefixime 11, 7
• These are NOT first-line (prefer nitrofurantoin, TMP-SMX, fosfomycin)
• Reserve for β-lactamase-producing organisms or first-line failures

Key Considerations for Selection

When to Choose Third-Generation Oral Cephalosporins:

1. β-lactamase-producing organisms (H. influenzae, M. catarrhalis) are suspected or documented 2, 9
2. Penicillin allergy (non-anaphylactic type)
3. Failure of first-line therapy (amoxicillin or amoxicillin-clavulanate)
4. High local resistance to first-line agents

When NOT to Use:

• Cefixime/ceftibuten for pneumococcal infections (inadequate activity) 2
• Anaerobic infections (consider clindamycin or metronidazole instead)
• MRSA infections (no activity; use clindamycin or other agents)

Common Pitfalls

1. Prescribing cefixime for sinusitis or pneumonia: This is inappropriate due to poor pneumococcal coverage 2
2. Assuming all third-generation cephalosporins are equivalent: They have different spectra, particularly against S. pneumoniae
3. Inadequate duration: Most infections require 5-10 days; some experts recommend treating until symptom-free plus 7 days 2
4. Ignoring local resistance patterns: Empiric selection should account for community resistance rates
5. Using as first-line when amoxicillin would suffice: These are generally more expensive and broader spectrum than necessary for most uncomplicated infections 6

Tolerability

All agents are generally well tolerated. Cefixime has the highest rate of diarrhea among the class 4, 6. Discontinuation rates due to adverse events are typically similar across agents, with diarrhea being the most common complaint in all age groups 4.